← back to search

Gongliang Du

Shanxi Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research topics from publications: piRNA-36741 regulates BMP2-mediated osteoblast differentiation via METTL3 controlled m6A modification; Peroxisome proliferator‐activated receptor gamma coactivator‐1α/HSF1 axis effectively alleviates lipopolysaccharide‐induced acute lung injury via suppressing oxidative stress and inflammatory response; Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma; Irisin attenuates lipopolysaccharide-induced acute lung injury by downregulating inflammatory cytokine expression through miR-199a-mediated Rad23b overexpression; S100B ranks as a new marker of multiple traumas in patients and may accelerate its development by regulating endothelial cell dysfunction; Comparative gene expression profiling of normal and human colorectal adenomatous tissues; Effect of Urolithin A on Bone Repair in Mice with Bone Defects. Representative work: The osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) is essential for bone formation, and its imbalance can lead to bone diseases such as osteoporosis. It is reported that PIWI-interacting RNA-36741 (piR-36741) is up-regulated during the osteogenic differentiation, but its role in regulating osteogenic differentiation remains unclear. Here, the primary human BMSCs were used to induce osteogenic differentiation, and the expression of piR-36741 and METTL3 (methyltransferase like 3) was up-regulated during the osteogenic differentiation of BMSCs. Moreover, interference with piR-36741 or METTL3 markedly hindered the osteogenic differentiation of BMSCs, which was manifeste Abstract Acute lung injury (ALI) interferes with lung function by causing pulmonary inflammation and oxidative stress. Suppressing intracellular reactive oxygen species (ROS) may block intracellular inflammation. Thus, the purpose of the current study was to investigate the roles of peroxisome proliferator‐activated receptor gamma coactivator‐1α (PGC1α)/HSF1 axis in an lipopolysaccharide (LPS)‐induced ALI murine model and in RAW264.7 macrophages. In the LPS‐administrated mouse model, the addition of PGC1α obviously ameliorated secretion of pro‐inflammatory mediators tumor necrosis factor‐α and Interleukin 6 as well as MCP‐1 expression triggered by LPS stimulation, accompanied with reduced in
h-index
citations
0
works
0
NIH funding
primary concept
email

Recent publications

piRNA-36741 regulates BMP2-mediated osteoblast differentiation via METTL3 controlled m6A modification
Aging 2021cited by 55position: lastdoi
Irisin attenuates lipopolysaccharide-induced acute lung injury by downregulating inflammatory cytokine expression through miR-199a-mediated Rad23b overexpression
Experimental Cell Research 2021cited by 20position: middledoi
Effect of Urolithin A on Bone Repair in Mice with Bone Defects
Tissue Engineering and Regenerative Medicine 2021cited by 5position: middledoi
Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma
Biochemical and Biophysical Research Communications 2019cited by 20position: middledoi
Peroxisome proliferator‐activated receptor gamma coactivator‐1α/HSF1 axis effectively alleviates lipopolysaccharide‐induced acute lung injury via suppressing oxidative stress and inflammatory response
Journal of Cellular Biochemistry 2018cited by 25position: middledoi
S100B ranks as a new marker of multiple traumas in patients and may accelerate its development by regulating endothelial cell dysfunction.
PubMed 2014cited by 19position: middle
Comparative gene expression profiling of normal and human colorectal adenomatous tissues
Oncology Letters 2014cited by 5position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Longyang Ma · Shanxi Medical University5 papers (2018–2021)Xingbo Dang · Shanxi Medical University5 papers (2014–2021)Jianmin Liu · University of Shanghai for Science and Technology3 papers (2021–2021)Wei Hu · Shanxi Medical University1 papers (2018–2018)Ruiting Liu · Tianjin University of Traditional Chinese Medicine1 papers (2014–2014)Wei Hu · Shanxi Medical University1 papers (2014–2014)Xingbo Dang · Shanxi Medical University1 papers (2018–2018)Xuehong Fang · Shanxi Medical University1 papers (2014–2014)Pei Wang · Nanjing University of Chinese Medicine1 papers (2018–2018)Zhiyong Fan · Hebei Medical University1 papers (2019–2019)Laishun Guan · Shanxi Medical University1 papers (2014–2014)Wengang Dong · Shanxi Medical University1 papers (2021–2021)Wei Dai · Fujian Medical University1 papers (2014–2014)Jun Li · Air Force Medical University1 papers (2014–2014)Yi Li · Ningbo University1 papers (2018–2018)Ming Chen · Shandong Academy of Chinese Medicine1 papers (2021–2021)Hui Wang · Hypertension Institute1 papers (2019–2019)Ruipeng Zhang · Shanxi Medical University1 papers (2014–2014)